Cibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close and Host Conference Call
Cibus (Nasdaq: CBUS), an agricultural biotechnology company specializing in proprietary gene editing technologies for plant trait development in seeds, has scheduled its fourth quarter 2024 financial results announcement for March 20, 2025, after market close.
The company will host a conference call and audio webcast at 4:30 p.m. ET to discuss financial results and company updates. U.S. participants can dial +1-877-300-8521, while international participants can use +1-412-317-6026.
A replay will be available until April 3, 2025, accessible by dialing +1-844-512-2921 (U.S.) or +1-412-317-6671 (International) with passcode 10196898. The webcast and slides will be available on the company's investor website for 90 days after the event.
Cibus (Nasdaq: CBUS), un'azienda di biotecnologie agricole specializzata in tecnologie proprietarie di editing genetico per lo sviluppo delle caratteristiche delle piante nei semi, ha programmato l'annuncio dei risultati finanziari del quarto trimestre 2024 per il 20 marzo 2025, dopo la chiusura del mercato.
L'azienda ospiterà una conferenza telefonica e un webcast audio alle 16:30 ET per discutere i risultati finanziari e gli aggiornamenti aziendali. I partecipanti statunitensi possono chiamare il +1-877-300-8521, mentre i partecipanti internazionali possono utilizzare il +1-412-317-6026.
Una registrazione sarà disponibile fino al 3 aprile 2025, accessibile componendo il +1-844-512-2921 (U.S.) o il +1-412-317-6671 (Internazionale) con il codice di accesso 10196898. Il webcast e le diapositive saranno disponibili sul sito web per gli investitori dell'azienda per 90 giorni dopo l'evento.
Cibus (Nasdaq: CBUS), una empresa de biotecnología agrícola especializada en tecnologías de edición genética propietarias para el desarrollo de características de plantas en semillas, ha programado el anuncio de sus resultados financieros del cuarto trimestre de 2024 para el 20 de marzo de 2025, después del cierre del mercado.
La empresa llevará a cabo una conferencia telefónica y un webcast de audio a las 4:30 p.m. ET para discutir los resultados financieros y las actualizaciones de la empresa. Los participantes de EE. UU. pueden marcar el +1-877-300-8521, mientras que los participantes internacionales pueden usar el +1-412-317-6026.
Una grabación estará disponible hasta el 3 de abril de 2025, accesible marcando el +1-844-512-2921 (EE. UU.) o el +1-412-317-6671 (Internacional) con el código de acceso 10196898. El webcast y las diapositivas estarán disponibles en el sitio web para inversores de la empresa durante 90 días después del evento.
Cibus (Nasdaq: CBUS)는 씨앗의 식물 특성 개발을 위한 독점 유전자 편집 기술을 전문으로 하는 농업 생명공학 회사로, 2024년 4분기 재무 결과 발표를 2025년 3월 20일 마감 후로 예정했습니다.
회사는 오후 4시 30분 ET에 재무 결과 및 회사 업데이트를 논의하기 위한 전화 회의 및 오디오 웹캐스트를 개최할 예정입니다. 미국 참가자는 +1-877-300-8521로 전화할 수 있으며, 국제 참가자는 +1-412-317-6026을 사용할 수 있습니다.
재생은 2025년 4월 3일까지 가능하며, +1-844-512-2921 (미국) 또는 +1-412-317-6671 (국제)로 전화하여 액세스할 수 있으며, 비밀번호는 10196898입니다. 웹캐스트 및 슬라이드는 이벤트 후 90일 동안 회사의 투자자 웹사이트에서 확인할 수 있습니다.
Cibus (Nasdaq: CBUS), une entreprise de biotechnologie agricole spécialisée dans les technologies d'édition génétique propriétaires pour le développement de traits de plantes dans les semences, a prévu l'annonce de ses résultats financiers du quatrième trimestre 2024 pour le 20 mars 2025, après la fermeture du marché.
L'entreprise organisera une conférence téléphonique et un webcast audio à 16h30 ET pour discuter des résultats financiers et des mises à jour de l'entreprise. Les participants américains peuvent composer le +1-877-300-8521, tandis que les participants internationaux peuvent utiliser le +1-412-317-6026.
Un enregistrement sera disponible jusqu'au 3 avril 2025, accessible en composant le +1-844-512-2921 (États-Unis) ou le +1-412-317-6671 (International) avec le code d'accès 10196898. Le webcast et les diapositives seront disponibles sur le site web des investisseurs de l'entreprise pendant 90 jours après l'événement.
Cibus (Nasdaq: CBUS), ein Unternehmen für landwirtschaftliche Biotechnologie, das sich auf proprietäre Technologien zur Genbearbeitung für die Entwicklung von Pflanzeneigenschaften in Samen spezialisiert hat, hat die Bekanntgabe seiner finanziellen Ergebnisse für das 4. Quartal 2024 für den 20. März 2025, nach Börsenschluss, angesetzt.
Das Unternehmen wird um 16:30 Uhr ET eine Telefonkonferenz und einen Audio-Webcast abhalten, um die finanziellen Ergebnisse und Unternehmensaktualisierungen zu besprechen. US-Teilnehmer können +1-877-300-8521 anrufen, während internationale Teilnehmer +1-412-317-6026 nutzen können.
Eine Aufzeichnung wird bis zum 3. April 2025 verfügbar sein, erreichbar unter +1-844-512-2921 (USA) oder +1-412-317-6671 (International) mit dem Zugangscode 10196898. Der Webcast und die Folien werden 90 Tage nach der Veranstaltung auf der Investorenseite des Unternehmens verfügbar sein.
- None.
- None.
SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report fourth quarter 2024 financial results on Thursday, March 20, 2025. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates.
Title: Cibus, Inc. Fourth Quarter 2024 Results Conference Call
Event Date: Thursday, March 20, 2025
Time: 4:30 p.m. ET
Participant Numbers: +1-877-300-8521 (U.S.), +1-412-317-6026 (International)
Event Link: https://investor.cibus.com/events
For interested individuals unable to join the conference call, a dial-in replay of the call will be available through Thursday, April 3, 2025 and can be accessed by dialing +1-844-512-2921 (U.S.), +1-412-317-6671 (International) and entering replay passcode: 10196898.
A live audio webcast of the call, along with accompanying slides, will be available under "News & Events” in the Investor section of the Company's website, investor.cibus.com. An archived webcast will be available on the Company's website for 90 days after the event.
About Cibus
Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately
Cibus Contacts:
Investor Relations
Karen Troeber
ktroeber@cibus.com
858-450-2636
Jeff Sonnek – ICR
jeff.sonnek@icrinc.com
Media Relations
Colin Sanford
colin@bioscribe.com
203-918-4347
FAQ
When will Cibus (CBUS) release its Q4 2024 earnings report?
How can investors join the Cibus (CBUS) Q4 2024 earnings call?
How long will the Cibus (CBUS) Q4 2024 earnings call replay be available?
What is the replay passcode for Cibus (CBUS) Q4 2024 earnings call?
